Supps By Science: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Supps By Science
Largest movements
- Stocks and contracts -€8,300
down €8,300 (-52.5%), from €15,800 to €7,500
- Cash -€8,018
down €8,018 (-58.8%), from €13,632 to €5,614
mainly Net result for the year (-€16,518) and Trade debts (-€5,201)
- Receivables within one year -€4,703
down €4,703 (-97.0%), from €4,849 to €146
of which Trade receivables: -€4,529
- Profit (loss) carried forward -€16,518
down €16,518 (-459.2%), from -€3,597 to -€20,115
- Trade debts -€5,201
down €5,201 (-83.7%), from €6,212 to €1,011
- Tax, wage and social debts +€706
new in 2025: €706
- Gross operating margin -€13,522
down €13,522 (-478.4%), from -€2,826 to -€16,349
- Other operating charges -€588
down €588 (-83.1%), from €708 to €120
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €35,286 | €14,272 | -€21,013 | -59.6% |
| Current assets | 29/58 | €35,286 | €14,272 | -€21,013 | -59.6% |
| Stocks and contracts in progress | 3 | €15,800 | €7,500 | -€8,300 | -52.5% |
| Stocks | 30/36 | €15,800 | €7,500 | -€8,300 | -52.5% |
| Amounts receivable within one year | 40/41 | €4,849 | €146 | -€4,703 | -97.0% |
| Trade receivables | 40 | €4,674 | €146 | -€4,529 | -96.9% |
| Other amounts receivable | 41 | €174 | - | -€174 | |
| Cash at bank and in hand | 54/58 | €13,632 | €5,614 | -€8,018 | -58.8% |
| Deferred charges and accrued income | 490/1 | €1,005 | €1,013 | +€8 | +0.8% |
| Total equity and liabilities | 10/49 | €35,286 | €14,272 | -€21,013 | -59.6% |
| Equity | 10/15 | €29,073 | €12,555 | -€16,518 | -56.8% |
| Contributions | 10/11 | €32,670 | €32,670 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€3,597 | -€20,115 | -€16,518 | -459.2% |
| Amounts payable | 17/49 | €6,212 | €1,717 | -€4,495 | -72.4% |
| Amounts payable within one year | 42/48 | €6,212 | €1,717 | -€4,495 | -72.4% |
| Trade debts | 44 | €6,212 | €1,011 | -€5,201 | -83.7% |
| Suppliers | 440/4 | €6,212 | €1,011 | -€5,201 | -83.7% |
| Taxes, remuneration and social security | 45 | - | €706 | +€706 | |
| Taxes | 450/3 | - | €706 | +€706 | |
| Other operating charges | 640/8 | €708 | €120 | -€588 | -83.1% |
| Gross operating margin | 9900 | -€2,826 | -€16,349 | -€13,522 | -478.4% |
| Operating profit (loss) | 9901 | -€3,534 | -€16,469 | -€12,934 | -366.0% |
| Financial income | 75/76B | - | €0 | +€0 | |
| Recurring financial income | 75 | - | €0 | +€0 | |
| Financial charges | 65/66B | €63 | €49 | -€14 | -21.6% |
| Recurring financial charges | 65 | €63 | €49 | -€14 | -21.6% |
| Profit (loss) for the period before taxes | 9903 | -€3,597 | -€16,518 | -€12,921 | -359.2% |
| Profit (loss) for the period | 9904 | -€3,597 | -€16,518 | -€12,921 | -359.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€3,597 | -€16,518 | -€12,921 | -359.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.